Identifying True Celiac Disease and Wheat Allergy in the Era of Fashion Driven Gluten-Free Diets.


Journal

International archives of allergy and immunology
ISSN: 1423-0097
Titre abrégé: Int Arch Allergy Immunol
Pays: Switzerland
ID NLM: 9211652

Informations de publication

Date de publication:
2019
Historique:
received: 12 11 2018
accepted: 21 01 2019
pubmed: 22 3 2019
medline: 17 7 2019
entrez: 22 3 2019
Statut: ppublish

Résumé

Diagnosing both celiac disease (CD) and wheat allergy (WA) might be challenging due to the increasingly popular gluten-free diets. This study investigates the value of anti-tissue transglutaminase IgA (tTGIgA) and wheat-specific IgE (WIgE), and identifies clinical and serological features associated with CD and WA. Serological markers of autoimmunity and allergy along with medical charts of patients assessed for tTGIgA and WIgE between 2010 and 2016 were evaluated. During the last years, an increasing number of patients have been tested for tTGIgA, while the number of positive results decreased linearly. Among the 2,965 patients included, 128 patients showed at least once a positive tTGIgA. All patients with tTGIgA levels higher than the 12-fold upper normal limit had CD. The ratio of tTGIgA/total IgA did not perform better as a diagnostic test for CD compared to tTGIgA. tTGIgA and anti-nuclear antibodies were significantly associated. WA was only rarely investigated, particularly in adults. However, positive WIgE were found in nearly 50% of the cases. WIgE and tTGIgA values were negatively correlated. tTGIgA were increasingly tested, while the rate of positive results decreased in recent years, possibly reflecting the impact of current alimentary trends on clinical practice. Associated autoimmune disease was frequently found in CD. High levels of tTGIgA accurately predicted CD diagnosis. WA was rarely investigated and deserves more attention, in particular in children with atopic background. WA does not seem to be associated with CD.

Sections du résumé

BACKGROUND
Diagnosing both celiac disease (CD) and wheat allergy (WA) might be challenging due to the increasingly popular gluten-free diets.
OBJECTIVES
This study investigates the value of anti-tissue transglutaminase IgA (tTGIgA) and wheat-specific IgE (WIgE), and identifies clinical and serological features associated with CD and WA.
METHOD
Serological markers of autoimmunity and allergy along with medical charts of patients assessed for tTGIgA and WIgE between 2010 and 2016 were evaluated.
RESULTS
During the last years, an increasing number of patients have been tested for tTGIgA, while the number of positive results decreased linearly. Among the 2,965 patients included, 128 patients showed at least once a positive tTGIgA. All patients with tTGIgA levels higher than the 12-fold upper normal limit had CD. The ratio of tTGIgA/total IgA did not perform better as a diagnostic test for CD compared to tTGIgA. tTGIgA and anti-nuclear antibodies were significantly associated. WA was only rarely investigated, particularly in adults. However, positive WIgE were found in nearly 50% of the cases. WIgE and tTGIgA values were negatively correlated.
CONCLUSIONS
tTGIgA were increasingly tested, while the rate of positive results decreased in recent years, possibly reflecting the impact of current alimentary trends on clinical practice. Associated autoimmune disease was frequently found in CD. High levels of tTGIgA accurately predicted CD diagnosis. WA was rarely investigated and deserves more attention, in particular in children with atopic background. WA does not seem to be associated with CD.

Identifiants

pubmed: 30897589
pii: 000497115
doi: 10.1159/000497115
doi:

Substances chimiques

Biomarkers 0
Immunoglobulin A 0
Immunoglobulin E 37341-29-0
Glutens 8002-80-0
Protein Glutamine gamma Glutamyltransferase 2 EC 2.3.2.13
Transglutaminases EC 2.3.2.13
GTP-Binding Proteins EC 3.6.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

132-141

Informations de copyright

© 2019 S. Karger AG, Basel.

Auteurs

David Spoerl (D)

Division of Immunology and Allergy, Department of Medical Specialties, University Hospital and Faculty of Medicine, Geneva, Switzerland, david.spoerl@hcuge.ch.
Division of Laboratory Medicine, Department of Pathology, Genetics and Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland, david.spoerl@hcuge.ch.

Caroline Bastid (C)

Division of Gastroenterology, Department of Medical Specialties, University Hospital and Faculty of Medicine, Geneva, Switzerland.

Salim Ramadan (S)

Pediatric Allergy Unit, University Hospitals of Geneva and University of Geneva, Geneva, Switzerland.

Jean-Louis Frossard (JL)

Division of Gastroenterology, Department of Medical Specialties, University Hospital and Faculty of Medicine, Geneva, Switzerland.

Jean-Christoph Caubet (JC)

Pediatric Allergy Unit, University Hospitals of Geneva and University of Geneva, Geneva, Switzerland.

Pascale Roux-Lombard (P)

Division of Immunology and Allergy, Department of Medical Specialties, University Hospital and Faculty of Medicine, Geneva, Switzerland.
Division of Laboratory Medicine, Department of Pathology, Genetics and Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH